bicalutamide and ovalbumin

bicalutamide has been researched along with ovalbumin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, L; Ma, X; Wu, G; Wu, X; Zhang, Q; Zhang, Y	1

Other Studies

1 other study(ies) available for bicalutamide and ovalbumin

Article	Year
Bicalutamide, an androgen receptor antagonist, effectively alleviate allergic rhinitis via suppression of PI3K-PKB activity. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023, Volume: 280, Issue:2 Topics: Androgen Receptor Antagonists; Animals; Cytokines; Disease Models, Animal; Immunoglobulin E; Interleukin-4; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Phosphatidylinositol 3-Kinases; Rhinitis, Allergic	2023

Article

Year

Bicalutamide, an androgen receptor antagonist, effectively alleviate allergic rhinitis via suppression of PI3K-PKB activity.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023, Volume: 280, Issue:2

Topics: Androgen Receptor Antagonists; Animals; Cytokines; Disease Models, Animal; Immunoglobulin E; Interleukin-4; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Phosphatidylinositol 3-Kinases; Rhinitis, Allergic

2023